Puma Biotechnology Inc (NASDAQ: PBYI) stock enjoyed a major increase of 12.3% on 8/6/24. The shares closed at $4.03. Moreover, trading volume in this advance was above average at 142% of normal. The stock has been weak relative to the market over the last nine months but has risen 11.6% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, PBYI is expected to continue to be a major Value Builder.
Puma Biotechnology has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Puma Biotechnology has a slightly negative Appreciation Score of 40 and a very low Power Rating of 15, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment